Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
LadRx Corporation is a biopharmaceutical company focused on oncology, developing targeted anti-cancer drug candidates using novel LADR technology that delivers potent chemotherapeutics directly to solid tumors via albumin binding. Its pipeline includes tumor-targeting conjugates and companion diagnostics, aiming to improve efficacy and reduce side effects. The company seeks licensing, partnerships, and regulatory approvals to commercialize its innovative therapies for cancer treatment.
This description was generated via AI from an annual report. Updated about 1 year ago.